Efficacy of lipid-lowering therapy beyond statins to prevent cardiovascular events: a meta-analysis

被引：4
|
作者：
Dykun, Iryna [1 ]
Mincu, Raluca [1 ]
Hendricks, Stefanie [1 ]
Balcer, Bastian [1 ]
Totzeck, Matthias [1 ]
Rassaf, Tienush [1 ]
Mahabadi, Amir A. [1 ]
机构：
[1] Univ Duisburg Essen, Dept Cardiol & Vasc Med, Essen, Germany
来源：
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY | 2020年 / 27卷 / 15期
关键词：
REDUCING LIPIDS; SAFETY; EZETIMIBE;
D O I：
10.1177/2047487319866992
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1675 / 1678
页数：4
相关论文
共 50 条
  • [31] Cardiovascular risk in patients with familial hypercholesterolemia using optimal lipid-lowering therapy
    Galema-Boers, Annette M.
    Lenzen, Mattie J.
    Engelkes, Sophie R.
    Sijbrands, Eric J.
    van Lennep, Jeanine E. Roeters
    JOURNAL OF CLINICAL LIPIDOLOGY, 2018, 12 (02) : 409 - 416
  • [32] Effectiveness of lipid-lowering therapy with statins for secondary prevention of atherosclerosis - guidelines vs. reality
    Bozentowicz-Wikarek, Maria
    Kocelak, Piotr
    Smertka, Mike
    Olszanecka-Glinianowicz, Magdalena
    Chudek, Jerzy
    PHARMACOLOGICAL REPORTS, 2012, 64 (02) : 377 - 385
  • [33] Effects of Combined Lipid-Lowering Therapy on Low-Density Lipoprotein Cholesterol Variability and Cardiovascular Adverse Events in Patients with Acute Coronary Syndrome
    Tan, Huilian
    Liu, Ling
    Zheng, Qinghou
    Zhang, Dahong
    Liu, Qian
    Cui, Dong
    Gao, Lei
    Wang, Zhen
    Wang, Wen-Lei
    Liu, Jun
    ADVANCES IN THERAPY, 2021, 38 (06) : 3389 - 3398
  • [34] Combination therapy with simvastatin and xuezhikang improves the lipid-lowering efficacy in hyperlipidemic rats
    Lin, Yang
    Cai, Ming
    Lin, Yanru
    Teng, Hong
    AFRICAN JOURNAL OF PHARMACY AND PHARMACOLOGY, 2012, 6 (30): : 2318 - 2321
  • [35] Efficacy and safety of bempedoic acid alone or combining with other lipid-lowering therapies in hypercholesterolemic patients: a meta-analysis of randomized controlled trials
    Xiang Zhao
    Xubiao Ma
    Xing Luo
    Zhihua Shi
    Ziwen Deng
    Yuanxiang Jin
    Zhipeng Xiao
    Liming Tan
    Pingfang Liu
    Shilong Jiang
    Yuanglu Shu
    Bing Tang
    Chengfeng Qiu
    BMC Pharmacology and Toxicology, 21
  • [36] Efficacy and safety of bempedoic acid alone or combining with other lipid-lowering therapies in hypercholesterolemic patients: a meta-analysis of randomized controlled trials
    Zhao, Xiang
    Ma, Xubiao
    Luo, Xing
    Shi, Zhihua
    Deng, Ziwen
    Jin, Yuanxiang
    Xiao, Zhipeng
    Tan, Liming
    Liu, Pingfang
    Jiang, Shilong
    Shu, Yuanglu
    Tang, Bing
    Qiu, Chengfeng
    BMC PHARMACOLOGY & TOXICOLOGY, 2020, 21 (01):
  • [37] Meta-Analysis of Effect and Efficacy of Statins in Type 2 Diabetes Mellitus with Cardiovascular Disease
    Li, Xiyu
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2024, 86 : 174 - 182
  • [38] Meta-analysis of the Placebo and Nocebo effects associated with Placebo treatment in randomized trials of lipid-lowering therapies
    Chin, Yip Han
    Lim, Oliver
    Lin, Chaoxing
    Chan, Yu Yi
    Kong, Gwyneth
    Ng, Cheng Han
    Chong, Bryan
    Syn, Nicholas
    Chan, Kai En
    Muthiah, Mark D.
    Siddiqui, Mohammad Shadab
    Wang, Jiong-Wei
    Figtree, Gemma
    Chan, Mark Y.
    Chew, Nicholas W. S.
    EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 2023, 9 (05) : 511 - 519
  • [39] Benefits of intensive lipid-lowering therapies in patients with acute coronary syndrome: a systematic review and meta-analysis
    Wu, Xian-Dan
    Ye, Xin-Yue
    Liu, Xuan-Yan
    Lin, Yue
    Lin, Xian
    Li, Yan-Yan
    Ye, Bin-Hua
    Sun, Jing-Chao
    ANNALS OF MEDICINE, 2024, 56 (01)
  • [40] Effect of Intensive and Standard Lipid-Lowering Therapy on the Progression of Stroke in Patients With Coronary Artery Syndromes: A Meta-Analysis of Randomized Controlled Trials
    Xie, Chengjuan
    Zhu, Mingyu
    Hu, Ying
    Wang, Kai
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2020, 75 (03) : 222 - 228
12345